U.S. market Closed. Opens in 2 days 1 hour 24 minutes

BLAC | Bellevue Life Sciences Acquisition Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/A
Operating Expenses1.83M35.39K3.31K23.81K
Selling, General & Admin1.83M35.39K3.31K23.81K
Research & DevelopmentN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/A
Operating Income-1.83M-35.39K-3.31K-23.81K
Other Expenses / Income2.78M2.002.00-2.00
Before Tax Income944.59K-35.39K-3.31K-23.81K
Income Tax Expenses540.81K-228.48K-236.56K-206.30K
Net Income403.78K-35.39K-3.31K-23.81K
Interest ExpensesN/AN/AN/AN/A
Basic Shares Outstanding5.62M9.05M7.93M7.89M
Diluted Shares Outstanding5.62M9.05M7.93M7.89M
EBITDA-1.83M-35.39K-3.31K-23.81K
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT944.59K-263.87K-239.86K-230.11K
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙